Compass Therapeutics Inc. (CMPX)
Official siteHEALTHCARE • BIOTECHNOLOGY • NASDAQ
Market Cap: $139.35M
Last updated: Nov 17, 2026 at 4:38 PM ET
Compass Therapeutics Inc. (CMPX) Stock Chart
Compass Therapeutics (CMPX) has a latest price of $0.61 on Nov 17, 2026. Its price fell 87.4% over the past 12 months. The month-end price fell 74.0% over the 5 years through Oct 2026, a compound annual decline of 23.6%.
Price Chart
From Apr 2021 to Oct 2026, its highest month-end close was $7.00 in Apr 2021 and its lowest $0.79 in Oct 2026, adjusted for splits.
Month-end closes, adjusted for splits. Dividends are not included.
Chart CMPX with Advanced Charting
Daily candlesticks, valuation multiples, side-by-side comparisons and drawings for CMPX.
Free with a GNG account. No credit card.
Price Performance
Over the past 3 months the price fell 75.5%, and over 6 months it fell 66.5%. The month-end price fell 56.3% over the 3 years through Oct 2026, a compound annual decline of 24.1%.
| Period | Change |
|---|---|
| 1 month | -27.3% |
| 3 months | -75.5% |
| 6 months | -66.5% |
| 12 months | -87.4% |
| 12 months, with dividends | -87.4% |
| Period | Change | Per year |
|---|---|---|
| 3 years | -56.3% | -24.1% |
| 5 years | -74.0% | -23.6% |
Price by Year
Its best calendar year was 2025, when the price rose 270.3%, and its weakest was 2023, when it fell 69.0%.
| Year | Close | Change |
|---|---|---|
| 2026 through Oct 2026 | $0.79 | -85.4% |
| 2025 | $5.37 | +270.3% |
| 2024 | $1.45 | -7.1% |
| 2023 | $1.56 | -69.0% |
| 2022 | $5.03 | +58.7% |
Trading Range
The price is 43.2% below its 50-day average of $1.07 and 78.9% below its 200-day average of $2.87.
| Measure | Value | Price vs |
|---|---|---|
| Latest price (Nov 17, 2026) | $0.61 | |
| 50-day average | $1.07 | -43.2% |
| 200-day average | $2.87 | -78.9% |
Price Risk
Over 3 years, its largest fall from a peak was 90.9%.
| Measure | Value |
|---|---|
| 1-year beta | 1.75 |
| Largest fall, 1 year | -90.9% |
| Largest fall, 3 years | -90.9% |
Advanced Charting Features
Advanced Charting is free with a GNG account, and signed-in members get it in place of the price chart above.
- Valuation multiples. Daily P/E, price to sales, cash flow and book value, PEG and PEGY, drawn behind the price wherever the company's data supports them.
- Price charts and drawings. Candlestick, OHLC, line and area charts with volume and earnings, dividend and split markers, plus trend lines, levels and notes kept in your account.
- Side-by-side compare. Two stocks next to each other on one metric and time span, each chart with its own price scale.
- Projections and saved views. Pick a start and an end point to see the price return, dividends and total return between them, and save views to open later.
Frequently Asked Questions About CMPX
What is CMPX's 1-year price change?
Compass Therapeutics's price fell 87.4% over the past 12 months. With dividends included, the 12-month total return was -87.4%.
What is CMPX's 5-year price change?
Compass Therapeutics's month-end price fell 74.0% over the 5 years through Oct 2026, a compound annual decline of 23.6%. These figures leave out dividends.
What is CMPX's beta?
Compass Therapeutics's 1-year beta against the S&P 500 is 1.75, so its price has moved more than the market over the past year. Its largest fall from a peak over the past year was 90.9%.
Is the CMPX chart free?
Yes. Advanced Charting for CMPX is free with a GNG account, and no credit card is needed. It adds daily candlestick and line charts with volume, valuation multiples, side-by-side comparisons, drawings and saved views.
CMPX pages: Overview, Charting, Earnings, Forecast, Financials, Statistics, Competitors